Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy

NCT02181335 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

684

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Respimat® Budesonide low dose
DRUG: Respimat® Budesonide high dose
DRUG: Turbohaler® Budesonide
DRUG: Placebo

Sponsor

Boehringer Ingelheim